This study investigates the impact of echo-endoscopy biopsy on circulating tumor cells in patients with pancreatic tumors. The study focuses on how the procedure might affect these cells.
The study evaluates the levels and characteristics of circulating tumor cells before and after the biopsy. It looks into aspects like the number of cells and their cytological features.
- Who can participate: Men and women aged 40 to 85 years old with a BMI less than 30 kg/m2 may participate. Participants should be suspected of having pancreatic cancer and require an ultrasound endoscopic biopsy or biliary drainage.
- Study details: Participants will have blood samples taken from the portal vein and peripheral blood before and after the echo-endoscopic biopsy to measure circulating tumor cells. A placebo is not involved in this study.
- Study timelines and visits: The study will last 1 month. The study requires 1 visit.
How understandable was the trial content above?
Hard to understand
Easy to understand